Facebook Twitter LinkedIn
CIS

CIS

The science and practice of human immunology

The science and practice of human immunology
| MENU |

Update in PID

April 25, 2013
Miami, Florida

The Update in PID is being held just prior to the 2013 CIS Annual Meeting in Miami, Florida and does require an additional registration fee.

Organizers:

Charlotte Cunningham-Rundles, MD, PhD, Mt. Sinai School of Medicine
Steven M. Holland, MD, NIAID, NIH
Kathleen E. Sullivan, MD, PhD, Children's Hospital of Philadelphia
Troy Torgerson, MD, PhD, University of Washington

Program Description

Derived from the need to understand how to treat primary immune deficiency diseases in the context of other diseases, the CIS developed the Update in Primary Immunodeficiency Diseases which is geared toward physicians and scientists who are involved in the evaluation and/or care of patients with primary immune deficiencies.

Participants should be pediatricians, internists, or scientists committed to the clinical management of patients with primary immunodeficiency diseases. These candidates may have backgrounds in immunology, adult medicine, rheumatology, hematology, laboratory immunology, or allergy/immunology.

Speakers will be selected based on their expertise in IBD, Lung Disease, Autoimmunity, and Allergy to discuss how they treat these diseases combined with primary immune deficiencies. There will also be didactic presentations on immune reconsitution and immunomodulation in PID and autoimmunity along with oral abstract presentations selected from submitted abstracts. The faculty members represent specific interests and also present state-of-the-art lectures on their subject of interest. The content will cover both practical, cutting edge and theoretical issues related to patient care.

Learning Objectives

  • Provide advanced training for physicians and researchers working in the field of primary immune deficiency that covers diagnosis, therapy and future trends related to the care of patients with primary immune deficiencies.
  • Facilitate interactions among clinicians of diverse training to promote multicenter clinical trials and to coordinate participation in existing clinical trials.
  • Improve recognition of primary immune deficiencies.
  • Improve understanding of the diagnostic issues and the pathophysiology of primary immune deficiencies.
  • Improve understanding of the appropriate interventions for these diseases.

Target Audience

This program is designed for allergist-immunologists, primary care physicians, nursing professionals specializing in immunology and other medical professionals who treat primary immunodeficiency diseases.

Interested in supporting the 2013 Update in PID? Contact Missy Dortman, CIS Associate Director of Programs, by phone at +1.414.224.8095 or by email at info@clinimmsoc.org.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Clinical Immunology Society (CIS). The CIS is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Clinical Immunology Society designates this live activity for a maximum of 7 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.